Giovanni Montesano Alcon, CenterVue-iCare, Omikron, Code C (Consultant/Contractor), Relayer, LtD, Code O (Owner), Alcon, Code R (Recipient);
Alessandro Rabiolo None;
David Garway-Heath AbbVie, Omikron, Santen, Roche, Carl Zeiss Meditec, CenterVue-iCare, Code C (Consultant/Contractor), Heidelberg Engineering, Santen, Janssen , Code F (Financial Support), T4, Moorfields MDT, ANSWERS, Visual Field Sensitivity Testing, Code P (Patent), Viatris, Omikron, Novartis, AbbVie, Code R (Recipient), European Glaucoma Society, Glaucoma Research Society, Code S (non-remunerative);
Dun Jack Fu None;
Gus Gazzard Alcon, Allergan/Abvie, Belkin Vision, Elios Vision, Genentech/Roche, Glaukos Corporation, McKinsey Consulting, Rayner, Reichert, Ripple Therapeutics, Santen, Sight Sciences, Thea, Vialase, Visufarma, Zeiss, Code C (Consultant/Contractor), NIHR-HTA, NIHR-EME, NIHE-RfPB, MRC (EAGLE trial), City University, European Glaucoma Society, Fight for Sight, British Council for Prevention of Blindness, Moorfields Eye Charity, Friends of Moorfields Charity, IGA-UK Royal College of Ophthalmologists, UKEGS, US-NIH (NEI), Code F (Financial Support), Alcon, Allergan/Abvie, Bausch & Lomb, Glaukos Corporation, Haag-Streit Group, Lumenis, Lumibird/Quantel/Ellex, Merck & Co, Reichert, Thea, Visufarma, Code R (Recipient);
Giovanni Ometto Alcon, Code C (Consultant/Contractor), Relayer, LtD, Code O (Owner);
David Crabb Apellis, Code C (Consultant/Contractor), Santen, Code F (Financial Support), Santen, Allergan/Abbvie, Janssen, Thea, Code R (Recipient);
Anthony Khawaja Abbvie, Aerie, Allergan, Google Health, Heidelberg Engineering, Novartis, Reichert, Santen, Thea, Topcon, Code C (Consultant/Contractor)